πŸ‡ΊπŸ‡Έ FDA
Patent

US 9012641

Crystalline forms of Prasugrel salts

granted A61PA61P7/00A61P7/02

Quick answer

US patent 9012641 (Crystalline forms of Prasugrel salts) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P7/00, A61P7/02, A61P9/00, A61P9/10